Canada launches Vital, a national hospital data platform backed by $210 million, starting with 160 hospitals

Canada's national health data platform Vital went live on June 23, 2026, backed by $210 million in government and institutional funding and initially linking 160 hospitals across Alberta, Ontario, and Quebec. The launch, held at St. Michael's Hospital in Toronto, was attended by roughly 250 participants from academia, industry, government, and the public sector, along with Evan Solomon, Canada's Minister of Artificial Intelligence and Digital Innovation.

The platform is coordinated from Unity Health Toronto and built to stream near real-time clinical data from member hospitals into a single, governed research and innovation environment. That data layer is intended to underpin the development and evaluation of clinical AI tools, support large-scale trials, and attract both domestic and international research partnerships.

What Vital is and how it is structured

Vital was co-founded by St. Michael's physicians Drs. Amol Verma and Fahad Razak, who serve as its national co-leads. The platform received $100 million through Canada's federal AI strategy, with the remaining funding coming from institutional and other government sources, as reported by Unity Health Toronto.

Three additional provinces, British Columbia, Manitoba, and Nova Scotia, have already indicated support for joining the network, which organizers say positions Vital as a future pan-Canadian platform. A Strategic Advisory Committee, chaired by former University of Toronto president Dr. David Naylor, provides oversight and strategic direction.

Governance is a central design principle. The platform operates under Canadian ownership and management of data, with provincial oversight built in. Verma, who also holds the Temerty Professor of AI Research and Education in Medicine chair at the University of Toronto, described national data sovereignty as a non-negotiable requirement for a resource of this scale, per Unity Health Toronto's reporting.

AI tools already in the field

Unity Health Toronto demonstrated two clinical AI applications at the launch event that illustrate the kind of work Vital is designed to scale nationally.

CHARTWatch, a patient monitoring tool developed at St. Michael's, continuously evaluates hospitalized patients for risk of unexpected death or unplanned transfer to an intensive care unit. A study published in the Canadian Medical Association Journal found a 26 percent reduction in unanticipated mortality on the hospital's general internal medicine unit after CHARTWatch was deployed. The tool currently runs on several units across Unity Health's acute care hospitals.

The second demonstration involved the AIM to Prevent Delirium trial, described by Unity Health Toronto as one of Canada's largest clinical trials of health AI. The tool predicts a patient's real-time risk of developing delirium during a hospital stay so prevention resources can be concentrated where they are most needed. Delirium affects roughly one in four adults hospitalized for medical or surgical conditions, according to a study indexed on PubMed. Up to 40 percent of cases are considered preventable.

The economic burden is substantial. A separate peer-reviewed study cited by Unity Health Toronto estimates delirium adds approximately $11,000 in costs per hospital admission, driven largely by extended lengths of stay. The AIM trial is currently enrolling 15,000 patients across 13 hospitals.

Why this matters for health system operators

For CIOs and operations leaders at Canadian health systems, Vital represents both an infrastructure commitment and a procurement question. Hospitals that join the network will need to evaluate data integration requirements, governance obligations under their respective provincial frameworks, and the readiness of their own data pipelines to feed near real-time feeds into a national platform.

Razak, citing Canada's single-payer system and what he described as the most diverse population among high-income countries, argued the data generated through Vital will carry global relevance for medical device and therapeutics developers, per Unity Health Toronto. That framing has direct implications for how health technology vendors approach Canada as a clinical evidence generation market.

Naylor, speaking at the event, pointed to the platform's potential to seed a generation of Canadian health AI startups and to position the country as a destination for international clinical trials with both public and private sponsors. The next visible milestone will be whether the three additional provinces that have signaled interest, BC, Manitoba, and Nova Scotia, complete formal onboarding agreements and when the first cross-provincial research outputs emerge from the platform.

What this means for your team

• Assess data readiness: hospitals that may join Vital need to audit whether their existing EHR and data infrastructure can support near real-time feeds and meet the platform's privacy and governance standards.
• Evaluate clinical AI procurement against Vital-validated tools: CHARTWatch's 26% mortality reduction in CMAJ gives procurement teams a published benchmark to use when evaluating competing patient-monitoring vendors.
• Track AIM to Prevent Delirium trial results: with 15,000 patients across 13 hospitals, the trial will produce one of the largest real-world evidence sets for AI-driven delirium prevention; outcomes should factor into care-pathway and length-of-stay reduction planning.
• Monitor provincial onboarding timelines: BC, Manitoba, and Nova Scotia participation will determine how quickly Vital becomes a true pan-Canadian data resource and whether your health network can access cross-provincial research outputs.